✦ LIBER ✦

850a The treatment-naive microbiome in early-onset Crohn's Disease

✍ Scribed by Gevers, Dirk; Kugathasan, Subra; Denson, Lee; Vázquez-Baeza, Yoshiki; Van Treuren, Will; Ren, Boyu; Schwager, Emma; Knights, Dan; Song, Se Jin; Yassour, Moran; Morgan, Xochitl; Kostic, Aleksandar D.; Luo, Chengwei; Gonzalez, Antonio; McDonald, Daniel; Haberman, Yael; Walters, Thomas D.; Baker, Susan S.; Rosh, Joel R.; Stephens, Michael C.; Heyman, Melvin B.; Markowitz, James; Baldassano, Robert; Griffiths, Anne M.; Sylvester, Francisco A.; Mack, David R.; Kim, Sandra; Crandall, Wallace; Hyams, Jeffrey S.; Huttenhower, Curtis; Knight, Rob; Xavier, Ramnik J.

Book ID: 122311099
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 143 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60512-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1744 Granulomatous Crohn's Disease Ass

Mo1744 Granulomatous Crohn's Disease Associates With Microbiome Separation and Increased C - Reactive Protein (CRP) Levels in Treatment Naïve Children

✍ Kellermayer, Richard; Mir, Sabina A.V.; Nagy-Szakal, Dorottya; Cox, Stephen B.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

P569 Adalimumab was more effective in th

P569 Adalimumab was more effective in the patients with bio-naive and early Crohn's disease

✍ Hisamatsu, T.; Matsuoka, K.; Naganuma, M.; Miyoshi, J.; Inoue, N.; Yajima, T.; M 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 50 KB

Early or late guided missile in the trea

Early or late guided missile in the treatment of Crohn's disease?

✍ R. Caprilli; E. Angelucci; A. Cocco 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Mycobacterium avium subspecies paratuber

Mycobacterium avium subspecies paratuberculosis in children with early-onset crohn's disease: A longitudinal follow-up study

✍ Josef Wagner; Winnie Sim; Ruth F. Bishop; Anthony G. Catto-Smith; Donald J.S. Ca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The IBD1 locus for susceptibility to Cro

The IBD1 locus for susceptibility to Crohn’s disease has a greater impact in Ashkenazi Jews with early onset disease

✍ Pradip N Akolkar; Beena Gulwani-Akolkar; Xing-Yu Lin; Zhifeng Zhou; Mark Daly; S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Long-term outcome of treatment with infl

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

✍ Valérie Crombé; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; Gwénola Vern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode